Children with familial hypercholesterolemia (FH) might benefit from early initiation of statin therapy, but whether this would be safe and efficacious is not clear. Wiegman and colleagues Article assessed the efficacy and safety of pravastatin therapy vs placebo in children aged 8 to 18 years with heterozygous FH. After 2 years, the authors found a trend toward regression of the carotid intima-media thickness (IMT) in the pravastatin group compared with a trend toward progression in the placebo group. They found no evidence that pravastatin had adverse effects on growth, sexual maturation, hormone levels or liver or muscle tissue. In an editorial, Article Gotto discusses the clinical challenges in determining appropriate preventive therapy for children with FH.
Grahic Jump Location
Some studies have suggested that antidepressant medications of the selective serotonin reuptake inhibitor (SSRI) class are associated with an increased risk of suicidal ideation and behaviors, particularly in children and adolescents. Jick and colleagues Article conducted a case-control study to assess the risk of nonfatal suicidal behavior or suicide in first-time recipients of an antidepressant. They compared the risks from the tricyclic antidepressant amitriptyline, or the SSRIs fluoxetine or paroxetine, to the risk from the tricyclic dothiepin. The authors found a significantly increased risk of suicidal behavior in the first 1 to 9 days following initiation of antidepressant therapy, which was similar for both the SSRIs and tricyclic antidepressants studied, and no additional risk in patients 10 to 19 years of age. In an editorial, Article Wessely and Kerwin discuss the difficulties of obtaining high-quality evidence of the safety and efficacy of antidepressant therapies to support regulatory and clinical decision making.
Roger and colleagues assessed trends in the incidence of heart failure and survival following diagnosis using 1979 through 2000 data from the Rochester Epidemiology Project in Olmsted County, Minnesota, to test their hypothesis that incidence has increased, but survival improved, with some variation by age and sex. They found no decline in the incidence of heart failure over the past 2 decades. Five-year survival improved over time, but these improvements were largely seen in younger men, with less improvement in women and the elderly.
Children receiving measles, mumps, and rubella (MMR) vaccine may experience a vaccine-associated fever, and some may have a febrile seizure. To assess the incidence of febrile seizures following MMR vaccination, Vestergaard and colleagues conducted a population-based cohort study of children in Denmark. They found that the rate of first febrile seizure increased during the first and second week following MMR vaccination but thereafter was close to the rate for unvaccinated children. The authors found no evidence of an increased risk of epilepsy in children who experienced a febrile seizure following MMR vaccination.
Reports in the media indicate that the US Food and Drug Administration is reconsidering approving low-dose statins for over-the-counter use, but critics say data supporting the free availability of these cholesterol-lowering drugs are lacking.
Preliminary evidence from women with viral cirrhosis suggests vitamin K2 (menaquinone) may reduce the risk of hepatocellular carcinoma.
A meta-analysis of data from 6 clinical trials revealed that administering glycoprotein IIb/IIIa antagonists at the time of first medical contact and before catheterization improves coronary patency compared with administration in the catheterization laboratory in patients with acute ST-segment elevation myocardial infarction.
Clinical Review
An evidence-based review of adult asthma therapy trials supports low-dose, inhaled corticosteroids as first-line therapy.
For your patients: Information about adult asthma.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.